Development of an Improved Oral Tablet Formulation of BNC210, a Negative Allosteric Modulator of the Alpha 7 Nicotinic Acetylcholine Receptor, Suitable for Evaluation as an Acute Treatment for Social Anxiety Disorder
NEUROPSYCHOPHARMACOLOGY（2022）
Key words
Social Anxiety Disorder, Acute Treatment, Phase II, Clinical Trial, BNC210
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined